Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab

A case report

Hitomi Umeguchi, Hiromasa Takenoshita, Hiroshi Inoue, Yuki Kurihara, Chihiro Sakaguchi, Seiichi Yano, Nao Hasuzawa, Shohei Sakamoto, Ryuichi Sakamoto, Kenji Ashida

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)449-451
Number of pages3
JournalJournal of Oncology Practice
Volume14
Issue number7
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Hypoparathyroidism
pembrolizumab

All Science Journal Classification (ASJC) codes

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Umeguchi, H., Takenoshita, H., Inoue, H., Kurihara, Y., Sakaguchi, C., Yano, S., ... Ashida, K. (2018). Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab: A case report. Journal of Oncology Practice, 14(7), 449-451. https://doi.org/10.1200/JOP.18.00076

Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab : A case report. / Umeguchi, Hitomi; Takenoshita, Hiromasa; Inoue, Hiroshi; Kurihara, Yuki; Sakaguchi, Chihiro; Yano, Seiichi; Hasuzawa, Nao; Sakamoto, Shohei; Sakamoto, Ryuichi; Ashida, Kenji.

In: Journal of Oncology Practice, Vol. 14, No. 7, 01.07.2018, p. 449-451.

Research output: Contribution to journalArticle

Umeguchi, H, Takenoshita, H, Inoue, H, Kurihara, Y, Sakaguchi, C, Yano, S, Hasuzawa, N, Sakamoto, S, Sakamoto, R & Ashida, K 2018, 'Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab: A case report', Journal of Oncology Practice, vol. 14, no. 7, pp. 449-451. https://doi.org/10.1200/JOP.18.00076
Umeguchi, Hitomi ; Takenoshita, Hiromasa ; Inoue, Hiroshi ; Kurihara, Yuki ; Sakaguchi, Chihiro ; Yano, Seiichi ; Hasuzawa, Nao ; Sakamoto, Shohei ; Sakamoto, Ryuichi ; Ashida, Kenji. / Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab : A case report. In: Journal of Oncology Practice. 2018 ; Vol. 14, No. 7. pp. 449-451.
@article{49ea00a5383d4390b3b696622dfe71ea,
title = "Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab: A case report",
author = "Hitomi Umeguchi and Hiromasa Takenoshita and Hiroshi Inoue and Yuki Kurihara and Chihiro Sakaguchi and Seiichi Yano and Nao Hasuzawa and Shohei Sakamoto and Ryuichi Sakamoto and Kenji Ashida",
year = "2018",
month = "7",
day = "1",
doi = "10.1200/JOP.18.00076",
language = "English",
volume = "14",
pages = "449--451",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "7",

}

TY - JOUR

T1 - Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab

T2 - A case report

AU - Umeguchi, Hitomi

AU - Takenoshita, Hiromasa

AU - Inoue, Hiroshi

AU - Kurihara, Yuki

AU - Sakaguchi, Chihiro

AU - Yano, Seiichi

AU - Hasuzawa, Nao

AU - Sakamoto, Shohei

AU - Sakamoto, Ryuichi

AU - Ashida, Kenji

PY - 2018/7/1

Y1 - 2018/7/1

UR - http://www.scopus.com/inward/record.url?scp=85050318849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050318849&partnerID=8YFLogxK

U2 - 10.1200/JOP.18.00076

DO - 10.1200/JOP.18.00076

M3 - Article

VL - 14

SP - 449

EP - 451

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 7

ER -